TuisBBN • SWX
add
Bellevue Group AG
Vorige sluiting
CHF 14,75
Dagwisseling
CHF 14,50 - CHF 14,80
Jaarwisseling
CHF 11,05 - CHF 24,30
Markkapitalisasie
195,19 m CHF
Gemiddelde volume
9,95 k
P/V-verhouding
13,08
Dividend-opbrengs
7,93%
Primêre beurs
SWX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(CHF) | Jun. 2024info | J/J-verandering |
---|---|---|
Inkomste | 18,41 m | -11,31% |
Bedryfskoste | 13,73 m | -10,56% |
Netto inkomste | 3,72 m | -7,22% |
Netto winsgrens | 20,18 | 4,61% |
Wins per aandeel | — | — |
EBITDA | — | — |
Effektiewe belastingkoers | 17,26% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(CHF) | Jun. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 30,49 m | 100,63% |
Totale bates | 138,75 m | -4,69% |
Totale aanspreeklikheid | 22,05 m | -24,81% |
Totale ekwiteit | 116,70 m | — |
Uitstaande aandele | 13,20 m | — |
Prys om te bespreek | 1,67 | — |
Opbrengs op bates | 10,71% | — |
Opbrengs op kapitaal | — | — |
Kontantvloei
Netto kontantverandering
(CHF) | Jun. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 3,72 m | -7,22% |
Kontant van bedrywe | 3,65 m | 137,31% |
Kontant van beleggings | — | — |
Kontant van finansiering | -8,10 m | 45,85% |
Netto kontantverandering | -4,17 m | 83,13% |
Beskikbare kontantvloei | — | — |
Meer oor
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
HUB
Gestig
1993
Webwerf
Werknemers
88